|
|
|
|
LEADER |
02886nam a2200433Ia 4500 |
001 |
10.1016-j.jpha.2020.12.002 |
008 |
220427s2021 CNT 000 0 und d |
020 |
|
|
|a 20951779 (ISSN)
|
245 |
1 |
0 |
|a Formation mechanisms of sub-micron pharmaceutical composite particles derived from far- and near-field Raman microscopy
|
260 |
|
0 |
|b Xi'an Jiaotong University
|c 2021
|
856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1016/j.jpha.2020.12.002
|
520 |
3 |
|
|a Surface enhanced Raman spectroscopy (SERS) and confocal Raman microscopy are applied to investigate the structure and the molecular arrangement of sub-micron furosemide and polyvinylpyrrolidone (furosemide/PVP) particles produced by spray flash evaporation (SFE). Morphology, size and crystallinity of furosemide/PVP particles are analyzed by scanning electron microscopy (SEM) and X-ray powder diffraction (XRPD). Far-field Raman spectra and confocal far-field Raman maps of furosemide/PVP particles are interpreted based on the far-field Raman spectra of pure furosemide and PVP precursors. Confocal far-field Raman microscopy shows that furosemide/PVP particles feature an intermixture of furosemide and PVP molecules at the sub-micron scale. SERS and surface-enhanced confocal Raman microscopy (SECoRM) are performed on furosemide, PVP and furosemide/PVP composite particles sputtered with silver (40 nm). SERS and SECoRM maps reveal that furosemide/PVP particle surfaces mainly consist of PVP molecules. The combination of surface and bulk sensitive analyses reveal that furosemide/PVP sub-micron particles are formed by the agglomeration of primary furosemide nano-crystals embedded in a thin PVP matrix. Interestingly, both far-field Raman microscopy and SECoRM provide molecular information on a statistically-relevant amount of sub-micron particles in a single microscopic map; this combination is thus an effective and time-saving tool for investigating organic sub-micron composites. © 2020 Xi'an Jiaotong University
|
650 |
0 |
4 |
|a aerosol
|
650 |
0 |
4 |
|a Article
|
650 |
0 |
4 |
|a confocal microscopy
|
650 |
0 |
4 |
|a Confocal Raman microscopy
|
650 |
0 |
4 |
|a controlled study
|
650 |
0 |
4 |
|a crystal structure
|
650 |
0 |
4 |
|a evaporation
|
650 |
0 |
4 |
|a furosemide
|
650 |
0 |
4 |
|a microscopy
|
650 |
0 |
4 |
|a nanocrystal
|
650 |
0 |
4 |
|a particle size
|
650 |
0 |
4 |
|a Pharmaceutic composites
|
650 |
0 |
4 |
|a povidone
|
650 |
0 |
4 |
|a Raman spectrometry
|
650 |
0 |
4 |
|a scanning electron microscopy
|
650 |
0 |
4 |
|a SERS
|
650 |
0 |
4 |
|a silver
|
650 |
0 |
4 |
|a Sub-micron particles
|
650 |
0 |
4 |
|a Surface characterization
|
650 |
0 |
4 |
|a surface enhanced Raman spectroscopy
|
650 |
0 |
4 |
|a surface property
|
650 |
0 |
4 |
|a X ray powder diffraction
|
700 |
1 |
|
|a Busby, Y.
|e author
|
700 |
1 |
|
|a Coty, J.-B.
|e author
|
700 |
1 |
|
|a Hübner, J.
|e author
|
700 |
1 |
|
|a Spitzer, D.
|e author
|
773 |
|
|
|t Journal of Pharmaceutical Analysis
|